Subsequent Event (Notes)

3 Months Ended

Sep. 30, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

NOTE 11–SUBSEQUENT EVENTS

On October 3, 2014, we acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical RTSM services, based in the United Kingdom. ClinIntel’s offerings will be combined into the ClinPhone® RTSM suite and are designed to make patient randomization and clinical supply chain solutions more efficient. Capabilities include advanced RTSM technologies for planning, forecasting and supply chain eLogistics.

The purchase price for the acquisition was approximately $8.4 million, plus up to an additional $16.2 million over a 21-month period following the acquisition date if ClinIntel achieves specific financial targets. We funded the acquisition through use of existing cash. We will include ClinIntel's results of operations in our PI segment. Due to the limited time since the acquisition date, we have not yet completed the initial accounting for this business combination.